A panel of F.D.A. advisers is set to discuss Merck’s Covid pill. by BY REBECCA ROBBINS AND CARL ZIMMER

If an expert committee votes to recommend it, the drug, molnupiravir, could be authorized within days for patients at high risk of severe illness.

Published: November 30, 2021 at 11:10AM

from NYT Health https://ift.tt/3lnhk2t